Very important information!
About Dr. Russell Blaylock:
Dr. Blaylock is a board certified neurosurgeon, author and lecturer. He attended the LSU School of Medicine in New Orleans and completed his general surgical internship and neurosurgical residency at the Medical University of South Carolina in Charleston, South Carolina.
During his residency he ran the neurology program for one year and did a fellowship in neurosurgery after his residency. For the past 25 years he has practiced neurosurgery in addition to having a nutritional practice. He recently retired from both practices to devote full time to nutritional studies and research.
During his residency training he worked with the eminent neurosurgeon, Dr. Ludwig Kempe. Together they developed the transcallosal removal of intraventricular tumors, which is still used today.
Dr. Blaylock presented their cases utilizing this technique to the Congress of Neurological Surgeons. They also developed the ventriculolymphatic shunt in the treatment of hydrocephalus.
In addition, they conducted neuroanatomical studies together with the aim of developing improved approaches in vascular intracranial surgery. He has continued a close personal friendship with Dr. Kempe over the ensuing years, who at age 91 continues to study neuroanatomy, ornithology and is an editor of a major journal on medieval studies.
Of special note, Dr. Kempe climbed the Himalayan mountains at age 87, a testament of his robust health and enduring love of adventure.. It was during his residency that Dr. Blaylock did much of the primary work on intraventricular monitoring of craniocerebral trauma patients, which was reported in the scientific literature.
He also worked closely with Dr. Peter Jannetta during Dr. Jennettas early research on vascular compression of the cranial nerves as a cause of trigeminal neuralgia and hemifacial spasm. Dr. Blaylock was one of the first neurosurgeons to utilize high-intensity nutritional supplementation in craniocerebral trauma patients, which met with great success.
1 of 3:
2 of 3:
3 of 3:
More information on swine flu and vaccination:
From the article:
What Squalene Does to Rats
A 2000 study published in the American Journal of Pathology demonstrated a single injection of the adjuvant squalene into rats triggered “chronic, immune-mediated joint-specific inflammation,” also known as rheumatoid arthritis.[vii]
The researchers concluded the study raised questions about the role of adjuvants in chronic inflammatory diseases.
What Squalene Does to Humans
A study conducted at Tulane Medical School and published in the February 2000 issue of Experimental Molecular Pathology included these stunning statistics:
” … the substantial majority (95%) of overtly ill deployed GWS (Gulf War Syndrome) patients had antibodies to squalene. All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not deploy, but had the same signs and symptoms as those who did deploy, had antibodies to squalene.
In contrast, none (0%) of the deployed Persian Gulf veterans not showing signs and symptoms of GWS have antibodies to squalene. Neither patients with idiopathic autoimmune disease nor healthy controls had detectable serum antibodies to squalene. The majority of symptomatic GWS patients had serum antibodies to squalene.”[xi]
According to Dr. Viera Scheibner, Ph.D., a former principle research scientist for the government of Australia:
“… this adjuvant [squalene] contributed to the cascade of reactions called “Gulf War Syndrome,” documented in the soldiers involved in the Gulf War.
The symptoms they developed included arthritis, fibromyalgia, lymphadenopathy, rashes, photosensitive rashes, malar rashes, chronic fatigue, chronic headaches, abnormal body hair loss, non-healing skin lesions, aphthous ulcers, dizziness, weakness, memory loss, seizures, mood changes, neuropsychiatric problems, anti-thyroid effects, anaemia, elevated ESR (erythrocyte sedimentation rate), systemic lupus erythematosus, multiple sclerosis, ALS (amyotrophic lateral sclerosis), Raynaud’s phenomenon, Sjorgren’s syndrome, chronic diarrhoea, night sweats and low-grade fevers.”[xii]
You will find more important information on swine flu at the end of this article.
According to Kathleen Sebelius, Secretary of the U.S. Department of Health and Human Services, your children should be the first target for mass swine flu vaccinations when school starts this fall.[i]
This is a ridiculous assumption for many reasons, not to mention extremely high risk.
In Australia, where the winter season has begun, Federal Health Minister Nicola Roxon is reassuring parents the swine flu is no more dangerous than regular seasonal flu. “Most people, including children, will experience very mild symptoms and recover without any medical intervention,” she said.[ii]
Sydney-based immunization specialist Robert Booy predicts swine flu might be fatal to about twice as many children in the coming year as regular influenza. Booy estimates 10-12 children could die from the H1N1 virus, compared with the five or six regular flu deaths seen among children in an average year in Australia.[iii]